# ProQR Therapeutics (PRQR) — News

PRQR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prqr/news

## Recent headlines

- [ProQR Therapeutics N.V.: H.C. Wainwright cuts target price to $8 from $12](https://www.ainvest.com/news/proqr-therapeutics-wainwright-cuts-target-price-8-12-2610) — AInvest Wire, Oct 1, 2026
  H.C. Wainwright & Co. has revised its price target for ProQR Therapeutics N.V. (Nasdaq: PRQR), lowering it from $12 to $8, according to recent analyst activity. The firm maintains a "Buy" rating on the stock, citing Progress in RNA editing pipeline . ProQR recently submitted a Clinical Trial…
- [ProQR Therapeutics NV - files to register resale of up to 3.03 mln ordinary shares - SEC filing](https://www.ainvest.com/news/proqr-therapeutics-nv-files-register-resale-3-03-mln-ordinary-shares-sec-filing-2607) — AInvest Wire, Jul 6, 2026
  ProQR Therapeutics N.V. (Nasdaq: PRQR) has filed with the U.S. Securities and Exchange Commission (SEC) to register the resale of up to 3.03 million of its ordinary shares. The filing, made under a registration statement, allows existing shareholders to sell their shares in the public market,…
- [ProQR Therapeutics NV - to use proceeds for research, clinical development, and general corporate purposes](https://www.ainvest.com/news/proqr-therapeutics-nv-proceeds-research-clinical-development-general-corporate-purposes-2606) — AInvest Wire, Jun 25, 2026
- [ProQR Therapeutics NV - Eli Lilly to purchase 5.1 mln ProQR shares at $1.81/share for $9.2 mln](https://www.ainvest.com/news/proqr-therapeutics-nv-eli-lilly-purchase-5-1-mln-proqr-shares-1-81-share-9-2-mln-2606) — AInvest Wire, Jun 25, 2026
  ProQR Therapeutics N.V. (Nasdaq: PRQR) announced that Eli Lilly and Company, an existing shareholder and strategic partner, agreed to purchase 3,523,538 ordinary shares in a concurrent private placement at a price per share of $3.50, resulting in total gross proceeds of approximately $12.3 million…
- [ProQR prices $50.0 million underwritten registered direct offering and concurrent private placement](https://www.ainvest.com/news/proqr-prices-50-0-million-underwritten-registered-direct-offering-concurrent-private-placement-2606) — AInvest Wire, Jun 25, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).